TrialSignal transduction and targeted therapy2026
Camrelizumab plus chemotherapy as induction therapy followed by concurrent chemoradiotherapy and camrelizumab consolidation in limited-stage small cell lung cancer: a randomized phase II trial.
Di Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.